title: Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competition.
abstract: To initiate membrane fusion and virus entry, herpes simplex virus (HSV) gD binds to a cellular receptor such as herpesvirus entry mediator (HVEM). HVEM is a tumor necrosis factor (TNF) receptor family member with four natural ligands that either stimulate (LIGHT and LTα) or inhibit (BTLA and CD160) T cell function. We hypothesized that the interaction of gD with HVEM affects the binding of natural ligands, thereby modulating the immune response during infection. Here, we investigated the effect that gD has on the interaction of HVEM with its natural ligands. First, HSV gD on virions or cells downregulates HVEM from the cell surface. Similarly, trans-interaction with BTLA or LIGHT also downregulates HVEM from the cell surface, suggesting that HSV may subvert a natural mechanism for regulating HVEM activity. Second, we showed that wild-type gD had the lowest affinity for HVEM compared with the four natural ligands. Moreover, gD directly competed for binding to HVEM with BTLA but not LTα or LIGHT, indicating the possibility that gD selectively controls HVEM signals. On the other hand, natural ligands influence the use of HVEM by HSV. For instance, soluble BTLA, LTα, and LIGHT inhibited the binding of wild-type gD to HVEM, and soluble BTLA and LTα blocked HSV infection of HVEM-expressing cells. Thus, gD is at the center of the interplay between HVEM and its ligands. It can interfere with HVEM function in two ways, by competing with the natural ligands and by downregulating HVEM from the cell surface.
authors.affiliation: Department of Microbiology, University of Pennsylvania, Philadelphia, PA, USA.
authors.forename: Katie M
authors.initials: KM
authors.lastname: Stiles
authors.forename: J Charles
authors.initials: JC
authors.lastname: Whitbeck
authors.forename: Huan
authors.initials: H
authors.lastname: Lou
authors.forename: Gary H
authors.initials: GH
authors.lastname: Cohen
authors.forename: Roselyn J
authors.initials: RJ
authors.lastname: Eisenberg
authors.forename: Claude
authors.initials: C
authors.lastname: Krummenacher
mesh_terms: D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D015536:Down-Regulation; D015870:Gene Expression; D006561:Herpes Simplex / Q000378:metabolism* / Q000821:virology; D018259:Herpesvirus 1, Human / Q000235:genetics / Q000502:physiology*; D006801:Humans; D051379:Mice; D011485:Protein Binding; D053240:Receptors, Tumor Necrosis Factor, Member 14 / Q000737:chemistry / Q000235:genetics* / Q000378:metabolism*; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14 / Q000235:genetics / Q000378:metabolism; D014759:Viral Envelope Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D053586:Virus Internalization
chemical_list: D053240:Receptors, Tumor Necrosis Factor, Member 14; D053326:Tumor Necrosis Factor Ligand Superfamily Member 14; D014759:Viral Envelope Proteins; C039447:glycoprotein D, Human herpesvirus 1
references.citation: J Virol. 2009 Mar;83(5):2237-45
references.pmid: 19073721
references.citation: J Immunol. 1978 Jan;120(1):130-6
references.pmid: 203630
references.citation: Virus Res. 1991 Mar;18(2-3):271-90
references.pmid: 1645908
references.citation: Biochem Biophys Res Commun. 2005 Dec 16;338(2):930-7
references.pmid: 16259945
references.citation: J Immunol. 2000 Oct 15;165(8):4397-404
references.pmid: 11035077
references.citation: J Exp Med. 1999 Oct 18;190(8):1103-14
references.pmid: 10523608
references.citation: Nat Immunol. 2008 Feb;9(2):176-85
references.pmid: 18193050
references.citation: Immunity. 2003 May;18(5):593-603
references.pmid: 12753737
references.citation: Nature. 1984 Dec 20-1985 Jan 2;312(5996):721-4
references.pmid: 6334807
references.citation: J Immunol. 2000 Apr 15;164(8):4105-10
references.pmid: 10754304
references.citation: J Immunol. 1998 Sep 15;161(6):2780-90
references.pmid: 9743336
references.citation: Immunol Rev. 2009 May;229(1):244-58
references.pmid: 19426226
references.citation: J Gen Virol. 2007 Aug;88(Pt 8):2106-2110
references.pmid: 17622611
references.citation: J Immunol. 1990 Mar 1;144(5):1942-53
references.pmid: 2155270
references.citation: J Biol Chem. 1998 Oct 16;273(42):27548-56
references.pmid: 9765287
references.citation: Science. 2000 Jun 30;288(5475):2351-4
references.pmid: 10875917
references.citation: J Biol Chem. 1995 Jun 2;270(22):13303-7
references.pmid: 7768931
references.citation: Mol Ther. 2001 Feb;3(2):160-8
references.pmid: 11237672
references.citation: Cell. 1999 Oct 1;99(1):13-22
references.pmid: 10520990
references.citation: J Virol. 1988 May;62(5):1486-94
references.pmid: 2833603
references.citation: Immunol Rev. 2004 Dec;202:49-66
references.pmid: 15546385
references.citation: J Clin Invest. 2005 Mar;115(3):711-7
references.pmid: 15696194
references.citation: J Biol Chem. 1997 May 30;272(22):14272-6
references.pmid: 9162061
references.citation: Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6244-9
references.pmid: 19332782
references.citation: J Virol. 2003 Jul;77(14):8127-40
references.pmid: 12829851
references.citation: J Biol Chem. 2000 May 12;275(19):14307-15
references.pmid: 10799510
references.citation: Cell Microbiol. 2008 Nov;10(11):2297-311
references.pmid: 18671825
references.citation: J Virol. 1998 Jul;72(7):5802-10
references.pmid: 9621040
references.citation: J Acquir Immune Defic Syndr. 1999 Jun 1;21(2):90-8
references.pmid: 10360799
references.citation: J Virol. 2003 May;77(9):5324-32
references.pmid: 12692234
references.citation: Oral Microbiol Immunol. 2002 Aug;17(4):215-23
references.pmid: 12121471
references.citation: J Biol Chem. 1997 May 30;272(22):14029-32
references.pmid: 9162022
references.citation: Nat Rev Immunol. 2006 Sep;6(9):671-81
references.pmid: 16932752
references.citation: Cell Mol Life Sci. 2008 Jun;65(11):1653-68
references.pmid: 18351291
references.citation: Nat Immunol. 2003 Jul;4(7):670-9
references.pmid: 12796776
references.citation: J Virol. 1998 Jul;72(7):5937-47
references.pmid: 9621056
references.citation: Gene. 1991 Feb 15;98(2):177-83
references.pmid: 2016060
references.citation: J Virol. 2005 Jun;79(11):6655-63
references.pmid: 15890903
references.citation: Cytokine Growth Factor Rev. 2008 Jun-Aug;19(3-4):277-84
references.pmid: 18511331
references.citation: Virology. 2010 Mar 30;399(1):109-119
references.pmid: 20089288
references.citation: J Virol. 1998 Sep;72(9):7091-8
references.pmid: 9696802
references.citation: J Biol Chem. 2003 Sep 19;278(38):36059-67
references.pmid: 12844494
references.citation: Trends Biochem Sci. 2002 Jan;27(1):19-26
references.pmid: 11796220
references.citation: Virology. 2001 Feb 1;280(1):7-18
references.pmid: 11162814
references.citation: Mol Immunol. 2000 Aug;37(11):665-73
references.pmid: 11164894
references.citation: Virology. 1994 Feb 15;199(1):67-80
references.pmid: 8116256
references.citation: J Immunol. 2009 Jan 1;182(1):63-71
references.pmid: 19109136
references.citation: Clin Exp Immunol. 1988 Nov;74(2):196-200
references.pmid: 3265654
references.citation: Gene. 1997 Dec 19;204(1-2):35-46
references.pmid: 9434163
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 13;102(37):13218-23
references.pmid: 16131544
references.citation: Cell. 1996 Nov 1;87(3):427-36
references.pmid: 8898196
references.citation: J Immunol. 2009 Dec 1;183(11):7286-96
references.pmid: 19915044
references.citation: J Virol. 1996 Sep;70(9):6076-82
references.pmid: 8709231
references.citation: Biochem Biophys Res Commun. 2006 Jun 16;344(4):1121-7
references.pmid: 16643847
references.citation: Virology. 2004 May 1;322(2):286-99
references.pmid: 15110526
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 25;102(4):1116-21
references.pmid: 15647361
references.citation: Cell. 1993 May 7;73(3):431-45
references.pmid: 8387891
references.citation: J Virol. 2005 Jan;79(2):1282-95
references.pmid: 15613355
references.citation: Virology. 2008 Mar 30;373(1):98-111
references.pmid: 18076965
references.citation: J Virol. 1997 Aug;71(8):6083-93
references.pmid: 9223502
references.citation: Cell. 2001 Feb 23;104(4):487-501
references.pmid: 11239407
references.citation: Immunol Rev. 2008 Jun;223:186-201
references.pmid: 18613837
references.citation: Science. 1998 Jun 5;280(5369):1618-20
references.pmid: 9616127
references.citation: Mol Cell. 2001 Jul;8(1):169-79
references.pmid: 11511370
references.citation: Immunity. 1998 Jan;8(1):21-30
references.pmid: 9462508
references.citation: J Virol. 2001 Jan;75(1):171-80
references.pmid: 11119586
references.citation: EMBO J. 2005 Dec 7;24(23):4144-53
references.pmid: 16292345
references.citation: Methods Mol Med. 1998;10:131-56
references.pmid: 21374226
references.citation: Nat Immunol. 2005 Jan;6(1):90-8
references.pmid: 15568026
references.citation: J Virol. 1994 Feb;68(2):766-75
references.pmid: 8289380
references.citation: Annu Rev Immunol. 2010;28:389-411
references.pmid: 20307212
references.citation: J Virol. 2002 Nov;76(21):10894-904
references.pmid: 12368332
references.citation: Science. 2008 Oct 10;322(5899):268-71
references.pmid: 18845757
references.citation: J Virol. 1996 Jun;70(6):3815-22
references.pmid: 8648717
references.citation: J Immunol. 2001 Dec 1;167(11):6330-7
references.pmid: 11714797
references.citation: J Biol Chem. 1997 May 23;272(21):13471-4
references.pmid: 9153189
references.citation: J Biol Chem. 2005 Nov 25;280(47):39553-61
references.pmid: 16169851
references.citation: Semin Immunopathol. 2009 Jul;31(2):207-21
references.pmid: 19495760
references.citation: J Immunol. 2006 Dec 15;177(12):8356-64
references.pmid: 17142732
references.citation: J Leukoc Biol. 2010 Feb;87(2):223-35
references.pmid: 20007250